AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS · Delayed Price · Currency is USD
0.0072
-0.0003 (-4.00%)
Oct 17, 2025, 3:56 PM EDT
AXIM Biotechnologies Market Cap
AXIM Biotechnologies has a market cap or net worth of $2.56 million as of October 17, 2025. Its market cap has increased by 69.07% in one year.
Market Cap
2.56M
Enterprise Value
9.34M
Revenue
92.90K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since October 9, 2013, AXIM Biotechnologies's market cap has increased from 1.98M to 2.56M, an increase of 29.32%. That is a compound annual growth rate of 2.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 2.56M | 322.59% |
| Dec 31, 2024 | 605.90K | -86.58% |
| Dec 29, 2023 | 4.52M | -12.57% |
| Dec 30, 2022 | 5.16M | -91.35% |
| Dec 31, 2021 | 59.71M | 10.19% |
| Dec 31, 2020 | 54.19M | 135.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 702.42M |
| Elite Pharmaceuticals | 660.06M |
| Veradigm | 500.94M |
| Nika Pharmaceuticals | 495.49M |
| Northwest Biotherapeutics | 347.69M |
| CytoDyn | 336.10M |
| Silence Therapeutics | 311.27M |
| American Oncology Network | 277.25M |